Bandele OJ, Osheroff N. Bioflavonoids as poisons of human topoisomerase IIα and IIβ. Biochemistry. 2007;46(20):6097-108.
Banerjee, S., Li, Y., Wang, Z., & Sarkar, F. H. (2008). Multi-targeted therapy of cancer by genistein. Cancer letters, 269(2), 226-242.
Calin, G. A., Liu, C.-G., Sevignani, C., Ferracin, M., Felli, N., Dumitru, C. D., . . . Dono, M. (2004). MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proceedings of the National Academy of Sciences, 101(32), 11755-11760.
Carroll, W. L., Loh, M., Biondi, A., & Willman, C. (2011). The Biology of acute lymphoblastic leukemia Childhood Leukemia (pp. 29-61): Springer.
Chiosea, S., Jelezcova, E., Chandran, U., Acquafondata, M., McHale, T., Sobol, R. W., & Dhir, R. (2006). Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma. The American journal of pathology, 169(5), 1812-1820.
Chiosea, S., Jelezcova, E., Chandran, U., Luo, J., Mantha, G., Sobol, R. W., & Dacic, S. (2007). Overexpression of Dicer in precursor lesions of lung adenocarcinoma. Cancer research, 67(5), 2345-2350.
Drobna, M., Szarzyńska-Zawadzka, B., & Dawidowska, M. (2018). T-cell acute lymphoblastic leukemia from miRNA perspective: Basic concepts, experimental approaches, and potential biomarkers. Blood reviews, 32(6), 457-472.
Garzon, R., Volinia, S., Liu, C.-G., Fernandez-Cymering, C., Palumbo, T., Pichiorri, F., . . . Nakamura, T. (2008). MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood, 111(6), 3183-3189.
Gebert, L. F., & MacRae, I. J. (2019). Regulation of microRNA function in animals. Nature reviews Molecular cell biology, 20(1), 21-37.
George, J., Banik, N. L., & Ray, S. K. (2010). Genistein induces receptor and mitochondrial pathways and increases apoptosis during BCL‐2 knockdown in human malignant neuroblastoma SK‐N‐DZ cells. Journal of neuroscience research, 88(4), 877-886.
Gounaris-Shannon, S., & Chevassut, T. (2013). The role of miRNA in haematological malignancy. Bone marrow research, 2013.
Hu, X., Wu, X., Liu, H., Cheng, Z., Zhao, Z., Xiang, C., . . . Qing, Y. (2019). Genistein‐induced DNA damage is repaired by nonhomologous end joining and homologous recombination in TK6 cells. Journal of Cellular Physiology, 234(3), 2683-2692.
Huang, W., Wan, C., Luo, Q., Huang, Z., & Luo, Q. (2014). Genistein-inhibited cancer stem cell-like properties and reduced chemoresistance of gastric cancer. International journal of molecular sciences, 15(3), 3432-3443.
Iacobucci, I., & Mullighan, C. G. (2017). Genetic basis of acute lymphoblastic leukemia. Journal of Clinical Oncology, 35(9), 975.
Kurzynska-Kokorniak, A., Koralewska, N., Pokornowska, M., Urbanowicz, A., Tworak, A., Mickiewicz, A., & Figlerowicz, M. (2015). The many faces of Dicer: the complexity of the mechanisms regulating Dicer gene expression and enzyme activities. Nucleic acids research, 43(9), 4365-4380.
Kwon, S. C., Baek, S. C., Choi, Y.-G., Yang, J., Lee, Y.-s., Woo, J.-S., & Kim, V. N. (2019). Molecular basis for the single-nucleotide precision of primary microRNA processing. Molecular cell, 73(3), 505-518. e505.
Li, Q., & Chen, H. (2011). Epigenetic modifications of metastasis suppressor genes in colon cancer metastasis. Epigenetics, 6(7), 849-852.
Li, X., Luo, X., Han, B., Duan, F., Wei, P., & Chen, Y. (2013). MicroRNA-100/99a, deregulated in acute lymphoblastic leukaemia, suppress proliferation and promote apoptosis by regulating the FKBP51 and IGF1R/mTOR signalling pathways. British journal of cancer, 109(8), 2189.
Luan, C., Yang, Z., & Chen, B. (2015). The functional role of microRNA in acute lymphoblastic leukemia: relevance for diagnosis, differential diagnosis, prognosis, and therapy. OncoTargets and therapy, 8, 2903.
Lyle, S., Hoover, K., Colpan, C., Zhu, Z., Matijasevic, Z., & Jones, S. N. (2014). Dicer cooperates with p53 to suppress DNA damage and skin carcinogenesis in mice. PloS one, 9(6), e100920.
Ma, Z., Swede, H., Cassarino, D., Fleming, E., Fire, A., & Dadras, S. S. (2011). Up-regulated Dicer expression in patients with cutaneous melanoma. PloS one, 6(6), e20494.
MacFarlane, L.-A., Gu, Y., Casson, A. G., & Murphy, P. R. (2010). Regulation of fibroblast growth factor-2 by an endogenous antisense RNA and by argonaute-2. Molecular Endocrinology, 24(4), 800-812.
Malla, A., & Ramalingam, S. (2018). Health Perspectives of an Isoflavonoid Genistein and its Quantification in Economically Important Plants Role of Materials Science in Food Bioengineering (pp. 353-379): Elsevier.
Mattson, M. P., & Bazan, N. G. (2012). Apoptosis and necrosis Basic Neurochemistry (pp. 663-676): Elsevier.
Merritt, W. M., Lin, Y. G., Han, L. Y., Kamat, A. A., Spannuth, W. A., Schmandt, R., . . . Nick, A. M. (2008). Dicer, Drosha, and outcomes in patients with ovarian cancer. New England Journal of Medicine, 359(25), 2641-2650.
Muller, P. A., Trinidad, A. G., Caswell, P. T., Norman, J. C., & Vousden, K. H. (2014). Mutant p53 regulates Dicer through p63-dependent and-independent mechanisms to promote an invasive phenotype. Journal of Biological Chemistry, 289(1), 122-132.
Piroozian, F., Bagheri Varkiyani, H., Koolivand, M., Ansari, M., Afsa, M., AtashAbParvar, A., & MalekZadeh, K. (2019). The impact of variations in transcription of DICER and AGO2 on exacerbation of childhood B‐cell lineage acute lymphoblastic leukaemia. International journal of experimental pathology.
Pokornowska, M., Milewski, M. C., Ciechanowska, K., Szczepańska, A., Wojnicka, M., Radogostowicz, Z., . . . Kurzynska-Kokorniak, A. (2019). The RNA–RNA base pairing potential of human Dicer and Ago2 proteins. Cellular and Molecular Life Sciences, 1-14.
Russo, M., Russo, G. L., Daglia, M., Kasi, P. D., Ravi, S., Nabavi, S. F., & Nabavi, S. M. (2016). Understanding genistein in cancer: The “good” and the “bad” effects: A review. Food chemistry, 196, 589-600.
Shen, J., Xia, W., Khotskaya, Y. B., Huo, L., Nakanishi, K., Lim, S.-O., . . . Chen, C.-H. (2013). EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2. Nature, 497(7449), 383.
Sheng, G.-Q., Zhang, J.-R., Pu, X.-P., Ma, J., & Li, C.-L. (2002). Protective effect of verbascoside on 1-methyl-4-phenylpyridinium ion-induced neurotoxicity in PC12 cells. European journal of pharmacology, 451(2), 119-124.
Simioni, C., Martelli, A. M., Zauli, G., Melloni, E., & Neri, L. M. (2019). Targeting mtor in acute lymphoblastic leukemia. Cells, 8(2), 190.
Slavov, S., Gimenes Teixeira, H., & Rego, E. (2010). The role of micro-ribonucleic acids in normal hematopoiesis and leukemic T-lymphogenesis. Brazilian Journal of Medical and Biological Research, 43(7), 619-626.
Thangavel, P., Puga-Olguín, A., Rodríguez-Landa, J. F., & Zepeda, R. C. (2019). Genistein as Potential Therapeutic Candidate for Menopausal Symptoms and Other Related Diseases. Molecules, 24(21), 3892.
Tomizawa, D., & Kiyokawa, N. (2017). Acute Lymphoblastic Leukemia Hematological Disorders in Children (pp. 33-60): Springer.
Tuli, H. S., Tuorkey, M. J., Thakral, F., Sak, K., Kumar, M., Sharma, A. K., . . . Bishayee, A. (2019). Molecular Mechanisms of Action of Genistein in Cancer: Recent Advances. Frontiers in Pharmacology, 10, 1336.
Wallaert, A., Van Loocke, W., Hernandez, L., Taghon, T., Speleman, F., & Van Vlierberghe, P. (2017). Comprehensive miRNA expression profiling in human T-cell acute lymphoblastic leukemia by small RNA-sequencing. Scientific reports, 7(1), 7901.
Wang, H., Li, Q., & Chen, H. (2012). Genistein affects histone modifications on Dickkopf-related protein 1 (DKK1) gene in SW480 human colon cancer cell line. PloS one, 7(7), e40955.
Wiemels, J. (2012). Perspectives on the causes of childhood leukemia. Chemico-biological interactions, 196(3), 59-67.
Zhang, Q., Bao, J., & Yang, J. (2019). Genistein-triggered anticancer activity against liver cancer cell line HepG2 involves ROS generation, mitochondrial apoptosis, G2/M cell cycle arrest and inhibition of cell migration. Archives of medical science: AMS, 15(4), 1001.